Close encounters of the small kind: Adverse effects of man-made materials interfacing with the nano-cosmos of biological systems

Annual Review of Pharmacology and Toxicology

Volumn 50, Issue , 2010, Pages 63-88

  Shvedova, Anna A ^a   Kagan, Valerian E ^b   Fadeel, Bengt ^c  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Engineered nanomaterial; Immune response; Nanosystems biology; Nanotoxicology; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; CARBON NANOTUBE; GOLD NANOPARTICLE; NANOMATERIAL; SINGLE WALLED NANOTUBE;

BIOLOGY; CELL ACTIVITY; CRYSTAL STRUCTURE; DOSE RESPONSE; DRUG COATING; GENOTOXICITY; HUMAN; IMMUNE SYSTEM; IN VIVO STUDY; INFLAMMATION; NANOTOXICOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; ANIMAL; CELL FUNCTION; DRUG EFFECT; NANOTECHNOLOGY; PARTICLE SIZE;

ANIMALS; CELL PHYSIOLOGICAL PHENOMENA; HUMANS; NANOSTRUCTURES; NANOTECHNOLOGY; NANOTUBES, CARBON; OXIDATIVE STRESS; PARTICLE SIZE;

EID: 71949102618     PISSN: 03621642     EISSN: 15454304     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.010909.105819     Document Type: Review

References (140)

1. Feynman RP. 1960. There's plenty of room at the bottom: an invitation to enter a new field of physics. Eng. Sci. 23:22-36
2. Wang J. 2009. Can man-made nanomachines compete with nature biomotors? ACS Nano 3:4-9
3. The Royal Society and The Royal Academy of Engineering (RS/RAE). 2004. Nanoscience and Nanotech-nologies: Opportunities and Uncertainties. London: RS/RAE
4. Fadeel B, Kagan V, Krug H, Shvedova A, Svartengren M, et al. 2007. There's plenty of room at the forum: potential risks and safety assessment of engineered nanomaterials. Nanotoxicology 1:73-84
5. nan'o tech nol'o gy n. 2006. Nat. Nanotechnol. 1:8-10
6. Data retrieved in April 2009 from the online resource, ISI Web of Knowledge (www.isiknowledge.com)
7. Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJ. 2004. Nanotoxicology: a new frontier in particle toxicology relevant to both the workplace and general environment and to consumer safety. Occup. Environ. Med. 61:727-728
8. Oberdörster G, Oberdörster E, Oberdö rster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113:823-839
9. SeatonA,DonaldsonK. 2005. Nanoscience, nanotoxicology, and the need to think small. Lancet365:923-924
10. Kipen HM, Laskin DL. 2005. Smaller is not always better: Nanotechnology yields nanotoxicology. Am. J. Physiol. Lung Cell. Mol. Physiol. 289:L696-97
11. Service RF. 2000. Is nanotechnology dangerous? Science 290:1526-1527
12. Augustine NR. 1997. Augustine's Laws. American Institute of Aeronautics and Astronautics Inc.
13. Beutler BA. 2009. TLRs and innate immunity. Blood 13:1399-1407
14. Jones R. 2006. What can biology teach us? Nat. Nanotech. 1:85-86
15. Alberts B. 1998. The cell as a collection of protein machines: preparing the next generation of molecular biologists. Cell 92:291-294
16. Goel A, Vogel V. 2008. Harnessing biological motors to engineer systems for nanoscale transport and assembly. Nat. Nanotechnol. 3:465-475
17. Van Den Heuvel MGL, Dekker C. 2007. Motor proteins at work for nanotechnology. Science 317:333-336
18. Buzea C, Pacheco II, Robbie K. 2007. Nanomaterials and nanoparticles: sources and toxicity. BioInter-Phases 2:MR17-71
19. Douglas T, Young M. 2006. Viruses: making friends with old foes. Science 312:873-875
20. Singh R, Kostarelos K. 2009. Designer adenoviruses for nanomedicine and nanodiagnostics. Trends Biotechnol. 27:220-229
21. Oberdörster G, Stone V, Donaldson K. 2007. Toxicology of nanoparticles: a historical perspective. Nanotoxicology 1:2-25
22. Kickhoefer VA, Han M, Raval-Fernandes S, Poderycki MJ, Moniz RJ, et al. 2009. Targeting vault nanoparticles to specific cell surface receptors. ACS Nano 3:27-36
23. Suprenant KA. 2002. Vault ribonucleoprotein particles: sarcophagi, gondolas, or safety deposit boxes? Biochemistry 41:14447-14454
24. Kowalski MP, Dubouix-Bourandy A, Bajmoczi M, Golan DE, Zaidi T, et al. 2007. Host resistance to lung infection mediated by major vault protein in epithelial cells. Science 317:130-132
25. Belting M, Wittrup A. 2008. Nanotubes, exosomes, and nucleic acid-binding peptides provide novel mechanisms of intercellular communication in eukaryotic cells: implications in health and disease. J. Cell Biol. 183:1187-1191
26. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. 2007. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9:654-659
27. Brinkmann V, Zychlinsky A. 2007. Beneficial suicide: why neutrophils die to make NETs. Nat. Rev. Microbiol. 5:577-582
28. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, et al. 2004. Neutrophil extracellular traps kill bacteria. Science 303:1532-1535
29. Onfelt B, Nedvetzki S,Yanagi K, Davis DM. 2004. Cutting edge: Membrane nanotubes connect immune cells. J. Immunol. 173:1511-1513
30. Gousset K, Schiff E, Langevin C, Marijanovic Z, Caputo A, et al. 2009. Prions hijack tunnelling nanotubes for intercellular spread. Nat. Cell Biol. 11:328-336
31. Laocharoensuk R, Burdick J, Wang J. 2008. Carbon-nanotube-induced acceleration of catalytic nanomo-tors. ACS Nano 2:1069-1075
32. LeDuc PR, Wong MS, Ferreira PM, Groff RE, Haslinger K, et al. 2007. Towards an in vivo biologically inspired nanofactory. Nat. Nanotechnol. 2:3-7
33. Gerber C, Lang HP. 2006. How the doors to the nanoworld were opened. Nat. Nanotechnol. 1:3-5
34. Vives G, Tour JM. 2009. Synthesis of single-molecule nanocars. Acc. Chem. Res. 42:473-487
35. Lewinski N, Colvin V, Drezek R. 2008. Cytotoxicity of nanoparticles. Small 4:26-49
36. Stern ST, McNeil SE. 2008. Nanotechnology safety concerns revisited. Toxicol. Sci. 101:4-21
37. 55 clusters. Small 1:841-844
38. Pan Y, Neuss S, Leifert A, Fischler M, Wen F, et al. 2007. Size-dependent cytotoxicity of gold nanopar-ticles. Small 3:1941-1949
39. Kagan VE, Bayir H, Shvedova AA. 2005. Nanomedicine and nanotoxicology: two sides of the same coin. Nanomedicine 1:313-316
40. Nabiev I, Mitchell S, Davies A, Williams Y, Kelleher D, et al. 2007. Nonfunctionalized nanocrystals can exploit a cell's active transport machinery delivering them to specific nuclear and cytoplasmic compartments. Nano Lett. 7:3452-3461
41. Conroy J, Byrne SJ, Gun'ko YK, Rakovich YP, Donegan JF, et al. 2008. CdTe nanoparticles display tropism to core histones and histone-rich cell organelles. Small 4:2006-2015
42. Porter AE, Gass M, Muller K, Skepper JN, Midgley PA, et al. 2007. Direct imaging of single-walled carbon nanotubes in cells. Nat. Nanotechnol. 2:713-717
43. Sargent LM, Shvedova AA, Hubbs AF, Lowry DT, Kashon ML, et al. 2009. Induction of aneuploidy by single-walled carbon nanotubes. Presented at Annu. Meet. Soc. Toxicol., 48th, Baltimore, Maryland, March 15-19
44. Pampaloni F, Florin EL. 2008. Microtubule architecture: inspiration for novel carbon nanotube-based biomimetic materials. Trends Biotechnol. 26:302-310
45. Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, et al. 2008. The effect of particle design on cellular internalization pathways. Proc. Natl. Acad. Sci. USA 105:11613-11618
46. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, et al. 2004. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 16:437-445
47. Jones C, Grainger DW. 2009. In vitro assessments of nanomaterial toxicity. Adv. Drug Deliv. Rev. 61:438-456
48. Shaw SY, Westly EC, Pittet MJ, Subramanian A, Schreiber SL, et al. 2008. Perturbational profiling of nanomaterial biologic activity. Proc. Natl. Acad. Sci. USA 105:7387-7392
49. 2 in a tracheal explant system. Am. J. Physiol. Lung Cell. Mol. Physiol. 274:L81-86
50. Gurr JR, Wang ASS, Chen CH, Jan KY. 2005. Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells. Toxicology 213:66-73
51. 2 nanoparticles. Exp. Cell Res. 305:51-62
52. Oberdörster G, Ferin J, Lehnert BE. 1994. Correlation between particle size, in vivo particle persistence, and lung injury. Environ. Health Perspect. 102:173-179
53. Monteiller C, Tran L, MacNee W, Faux S, Jones A, et al. 2007. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup. Environ. Med. 64:609-615
54. Fadeel B,Garcia-Bennett A.2009.Better safe than sorry: understanding the hazardous effectsofinorganic nanomaterials manufactured for biomedical applications. Adv. Drug Deliv. Rev. In press
55. Sayes CM, Wahi R, Kurian PA, Liu Y, West JL, et al. 2006. Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol. Sci. 92:174-185
56. Warheit DB, Webb TR, Colvin VL, Reed KL, Sayes CM. 2007. Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but on surface characteristics. Toxicol. Sci. 95:270-280
57. Hussain SM, Braydich-Stolle LK, Schrand AM, Murdock RC, Yu KO, et al. 2009. Toxicity evaluation for safe use of nanomaterials: recent achievements and technical challenges. Adv. Mater. 21:1-11
58. Vallhov H, Qin J, Johansson SM, Ahlborg N, Muhammed MA, et al. 2006. The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. Nano Lett. 6:1682-1686
59. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. 2005. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1:325-327
60. Kagan VE, Tyurina YY, Tyurin VA, Konduru NV, Potapovich AI, et al. 2006. Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of iron. Toxicol. Lett. 165:88-100
61. Schrand AM, Braydich-Stolle LK, Schlager JJ, Dai L, Hussain SM. 2008. Can silver nanoparticles be useful as potential biological labels? Nanotechnology 19:104-117
62. Zetterström R. 2009. The 1908 Nobel Prize: discovery of the basic principles of innate and acquired immunity. Acta Paediatr. 98:1066-1069
63. Aderem A, Underhill DM. 1999. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17:593-623
64. Witasp E, Kagan V, Fadeel B. 2008. Programmed cell clearance: molecular mechanisms and role in autoimmune disease, chronic inflammation, and anti-cancer immune responses. Curr. Immunol. Rev. 4:53-69
65. Sadauskas E, Wallin H, Stoltenberg M, Vogel U, Doering P, et al. 2007. Kupffer cells are central in the removal of nanoparticles from the organism. Part. Fibre Toxicol. 4:10
66. Geiser M, Casaulta M, Kupferschmid B, Schulz H, Semmler-Behnke M, et al. 2008. The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am. J. Respir. Cell. Mol. Biol. 38:371-376
67. Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, et al. 2008. Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol. 38:1404-1413
68. Dobrovolskaia MA, McNeil SE. 2007. Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2:469-478
69. Chang E, Thekkek N, Yu WW, Colvin VL, Drezek R. 2006. Evaluation of quantum dot cytotoxicity based on intracellular uptake. Small 2:1412-1417
70. Geiser M, Rothen-Rutishauser B, Kapp N, Schürch S, Kreyling W, et al. 2005. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ. Health Perspect. 113:1555-1560
71. Nagayama S, Ogawara K, Minato K, Fukuoka Y, Takakura Y, et al. 2007. Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor. Int. J. Pharm. 329:192-198
72. Xing X, He X, Peng J, Wang K, Tan W. 2005. Uptake of silica-coated nanoparticles by HeLa cells. J. Nanosci. Nanotechnol. 5:1688-1693
73. Lundborg M, Dahlen SE, Johard U, Gerde P, Jarstrand C, et al. 2006. Aggregates of ultrafine particles impair phagocytosis of microorganisms by human alveolar macrophages. Environ. Res. 100:197-204
74. Witasp E, Shvedova AA, Kagan VE, Fadeel B. 2009. Single-walled carbon nanotubes impair human macrophage engulfment of apoptotic cell corpses. Inhal. Toxicol. 21:131-136
75. Yamawaki H, Iwai N. 2006. Cytotoxicity of water-soluble fullerene in vascular endothelial cells. Am. J. Physiol. Cell Physiol. 290:C1495-502
76. Seleverstov O, Zabirnyk O, Zscharnack M, Bulavina L, Nowicki M, et al. 2006. Quantum dots for human mesenchymal stem cells labeling. A size-dependent autophagy activation. Nano Lett. 6:2826-2832
77. Stern ST, Zolnik BS, McLeland CB, Clogston J, Zheng J, et al. 2008. Induction of autophagy in porcine kidney cells by quantum dots: A common cellular response to nanomaterials? Toxicol. Sci. 106:140-152
78. Sanjuan MA, Dillon CP, Tait SW, Moshiach S, Dorsey F, et al. 2007. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 450:1253-1257
79. Virgin HW, Levine B. 2009. Autophagy genes in immunity. Nat. Immunol. 10:461-470
80. Delgado M, Singh S, De Haro S, Master S, Ponpuak M, et al. 2009. Autophagy and pattern recognition receptors in innate immunity. Immunol. Rev. 227:189-202
81. Liu Z, Cai W, He L, Nakayama N, Chen K, et al. 2007. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol. 2:47-52
82. Rosenholm JM, Meinander A, Peuhu E, Niemi R, Eriksson JE, et al. 2009. Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano 3:197-206
83. Konduru NV, Tyurina YY, Feng W, Basova LV, Belikova NA, et al. 2009. Phosphatidylserine targets single-walled carbon nanotubes to professional phagocytes in vitro and in vivo. PLoS ONE 4(2):e4398
84. Wright AE, Douglas SR. 1904. An experimental investigation of the role of blood fluids in connection with phagocytosis. Proc. R. Soc. London 72:357-370
85. Vroman L. 1962. Effect of absorbed proteins on the wettability of hydrophilic and hydrophobic solids. Nature 196:476-477
86. Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S, et al. 2007. The nanoparticle-protein complex as a biological entity: a complex fluids and surface science challenge for the 21st century. Adv. Colloid Interface Sci. 134-135:167-174
87. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. 2009. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 61:428-437
88. Dutta D, Sundaram SK, Teeguarden JG, Riley BJ, Fifield LS, et al. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol. Sci. 100:303-315
89. Cedervall T, Lynch I, Lindman S, Bergga?rd T, Thulin E, et al. 2007. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl. Acad. Sci. USA 104:2050-2055
90. Cedervall T, Lynch I, Foy M, Bergga?rd T, Donnelly SC, et al. 2007. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem. Int. Ed. Engl. 46:5754-5756
91. Ehrenberg MS, Friedman AE, Finkelstein JN, Oberdörster G, McGrath JL. 2009. The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials 30:603-610
92. Dobrovolskaia MA, Patri AK, Zheng J, Clogston JD, Ayub N, et al. 2009. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine 5:106-117
93. Jones G, Brooks PM. 1996. Injectable gold compounds: an overview. Br. J. Rheumatol. 35:1154-1158
94. Schipper ML, Nakayama-Ratchford N, Davis CR, Kam NW, Chu P, et al. 2008. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat. Nanotechnol. 3:216-221
95. Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML. 2009. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv. Drug Deliv. 61:457-466
96. Park JH, Gu L, von Maltzahn G, Ruoslahti E, Bhatia SN, et al. 2009. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat. Mater. 8:331-336
97. Allen BL, Kichambare PD, Gou P, Vlasova II, Kapralov AA, et al. 2008. Biodegradation of single-walled carbon nanotubes through enzymatic catalysis. Nano Lett. 8:3899-3903
98. Loscalzo J. 2008. Membrane redox state and apoptosis: death by peroxide. Cell Metab. 8:182-183
99. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, et al. 2006. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 6:1794-1807
100. Xia T, Kovochich M, Liong M, Mädler L, Gilbert B, et al. 2008. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2:2121-2134
101. Yang H, Liu C, Yang D, Zhang H, Xi Z. 2009. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J. Appl. Toxicol. 29:69-78
102. D́?az B, Sánchez-Espinel C, Arruebo M, Faro J, de Miguel E, et al. 2008. Assessing methods for blood cell cytotoxic responses to inorganic nanoparticles and nanoparticle aggregates. Small 4:2025-2034
103. Bladh K, Falk LKL, Rohmund F. 2000. On the iron-catalyzed growth of single-walled carbon nanotubes and encapsulated metal particles in the gas phase. Appl. Phys. A 70:317-322
104. Mehta R, Templeton DM, O'Brien PJ. 2006. Mitochondrial involvement in genetically determined transition metal toxicity II. Copper toxicity. Chem. Biol. Interact. 163:77-85
105. Huang XP, O'Brien PJ, Templeton DM. 2006. Mitochondrial involvement in genetically determined transition metal toxicity I. Iron toxicity. Chem. Biol. Interact. 163:68-76
106. MacKenzie EL, Iwasaki K, Tsuji Y. 2008. Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid. Redox. Signal. 10:997-1030
107. Bergamaschi E, Bussolati O, Magrini A, Bottini M, Migliore L, et al. 2006. Nanomaterials and lung toxicity: interactions with airways cells and relevance for occupational health risk assessment. Int. J. Immunopathol. Pharmacol. 19:3-10
108. Shvedova AA, Kisin ER, Porter D, Schulte P, Kagan VE, et al. 2009. Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus? Pharmacol. Ther. 121:192-204
109. Shvedova AA, Kisin ER, Murray AR, Gorelik O, Arepalli S, et al. 2007. Vitamin E deficiency enhances pulmonary inflammatory response and oxidative stress induced by single-walled carbon nanotubes in C57BL/6 mice. Toxicol. Appl. Pharmacol. 221:339-348
110. Monteiro-Riviere NA, Inman AO, Zhang LW. 2009. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmacol. 234:222-235
111. Van Houten B, Woshner V, Santos JH. 2006. Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair (Amst.) 5:145-152
112. Murphy MP. 2009. How mitochondria produce reactive oxygen species. Biochem. J. 417:1-13
113. Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, et al. 2005. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat. Chem. Biol. 1:223-232
114. Tyurin VA, Tyurina YY, Jung MY, Tungekar MA, Wasserloos KJ, et al. 2009. Mass-spectrometric analysis of hydroperoxy-and hydroxy-derivatives of cardiolipin and phosphatidylserine in cells and tissues induced by pro-apoptotic and pro-inflammatory stimuli. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877:2863-2872
115. Kagan VE, Gleiss B, Tyurina YY, Tyurin VA, Elenström-Magnusson C, et al. 2002. A role for oxida-tive stress in apoptosis: oxidation and externalization of phosphatidylserine is required for macrophage clearance of cells undergoing Fas-mediated apoptosis. J. Immunol. 169:487-499
116. 2SO-differentiated HL-60 cells. Role in phagocytic clearance. J. Biol. Chem. 277:49965-49975 (Pubitemid 36014447)
117. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, et al. 2005. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 289:L698-708
118. Shvedova AA, Kisin E, Murray AR, Johnson VJ, Gorelik O, et al. 2008. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am. J. Physiol. Lung Cell. Mol. Physiol. 295:L552-65
119. Kinnula VL. 2005. Production and degradation of oxygen metabolites during inflammatory states in the human lung. Curr. Drug Targets Inflamm. Allergy 4:465-470
120. Shvedova AA, Kisin ER, Murray AR, Kommineni C, Castranova V, et al. 2008. Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes. Toxicol. Appl. Pharmacol. 231:235-240
121. Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman BT, et al. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674-677
122. Huang J, Canadien V, Lam GY, Steinberg BE, Dinauer MC, et al. 2009. Activation of antibacterial autophagy by NADPH oxidases. Proc. Natl. Acad. Sci. USA 106:6226-6231
123. Brennan ML, Hazen SL. 2003. Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment. Curr. Opin. Lipidol. 14:353-359
124. Kagan VE, Borisenko GG, Tyurina YY, Tyurin VA, Jiang J, et al. 2004. Oxidative lipidomics of apoptosis: redox catalytic interactionsofcytochromecwith cardiolipin and phosphatidylserine. Free Radic. Biol. Med. 37:1963-1985
125. Fischer HC, Chan WC. 2007. Nanotoxicity: the growing need for in vivo study. Curr. Opin. Biotechnol. 18:565-571
126. Card JW, Zeldin DC, Bonner JC, Nestmann ER. 2008. Pulmonary applications and toxicity of engineered nanoparticles. Am. J. Physiol. Lung Cell. Mol. Physiol. 295:L400-11
127. Peters A, Wichmann HE, Tuch T, Heinrich J, Heyder J. 1997. Respiratory effects are associated with the number of ultrafine particles. Am. J. Respir Crit. Care Med. 155:1376-1383
128. Penttinen P, Timonen KL, Tiittanen P, Mirme A, Ruuskanen J, et al. 2001. Number concentration and size of particles in urban air: effects on spirometric lung function in adult asthmatic subjects. Environ. Health Perspect. 109:319-323
129. Baron PA, Deye GJ, Chen BT, Schwegler-Berry DE, Shvedova AA, et al. 2008. Aerosolization of single-walled carbon nanotubes for an inhalation study. Inhal. Toxicol. 20:751-760
130. Mitchell LA, Gao J, Wal RV, Gigliotti A, Burchiel SW, et al. 2007. Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol. Sci. 100:203-214
131. Ryman-Rasmussen JP, Tewksbury EW, Moss OR, Cesta MF, Wong BA,et al. 2009. Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma. Am. J. Respir. Cell. Mol. Biol. 40:349-358
132. Park EJ, Cho WS, Jeong J, Yi J, Choi K, et al. 2009. Pro-inflammatory and potential allergic responses resulting from B cell activation in mice treated with multi-walled carbon nanotubes by intratracheal instillation. Toxicology 259:113-121
133. Shvedova AA, Fabisiak JP, Kisin ER, Murray AR, Roberts JR, et al. 2008. Sequential exposure to carbon nanotubes and bacteria enhances pulmonary inflammation and infectivity. Am. J. Respir. Cell. Mol. Biol. 38:579-590
134. Nygaard UC, Hansen JS, Samuelsen M, Alberg T, Marioara CD, et al. 2009. Single-walled and multi-walled carbon nanotubes promote allergic immune responses in mice. Toxicol. Sci. 109:113-123
135. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, et al. 2008. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 3:423-428
136. +/- mouse by intraperitoneal application of multi-wall carbon nanotube. J. Toxicol. Sci. 33:105-116
137. Homer, The Illiad, 1990
138. Xia T, Li N, Nel AE. 2009. Potential health impact of nanoparticles. Annu. Rev. Public Health [Epub ahead of print] doi: 10.1146/annurev.publhealth. 031308.100155
139. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, et al. 2006. Safe handling of nanotechnology. Nature 444:267-269
140. Tyurin VA, Tyurina YY, Kochanek PM, Hamilton R, DeKosky ST, et al. 2008. Oxidative lipidomics of programmed cell death. Methods Enzymol. 442:375-393